Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children

Aim:  Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of paediatrics and child health 2010-07, Vol.46 (7-8), p.404-411
Hauptverfasser: Wolf, Joshua, Daley, Andrew J, Tilse, Martyn H, Nimmo, Graeme R, Bell, Sydney, Howell, Alison J, Keil, Anthony D, Lawrence, Andrew, Curtis, Nigel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 411
container_issue 7-8
container_start_page 404
container_title Journal of paediatrics and child health
container_volume 46
creator Wolf, Joshua
Daley, Andrew J
Tilse, Martyn H
Nimmo, Graeme R
Bell, Sydney
Howell, Alison J
Keil, Anthony D
Lawrence, Andrew
Curtis, Nigel
description Aim:  Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population. Methods:  We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults. Results:  Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients. Conclusions:  These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.
doi_str_mv 10.1111/j.1440-1754.2010.01751.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754559435</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754559435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EoqXwCshiwyrDdfyTZMFiNIIpVVUqFVQJCVmO46gePHFqO2Lm7XGYdhZsqBe-x_Z3rnR9EMIEFiSvD5sFYQwKUnG2KCHfQpZksXuGTo8Pz7MGygpWEzhBr2LcAEDJef0SnZTAmSBATtHP5ZBsa32yGscpajPOR2fTHo8qJROGiH2Pb5Ia7_bOa6_1FLGagsnFRu9UMhH3wW_xcoopKGfVgPWddV0ww2v0olcumjcP9Qx9__zp2-q8uPy6_rJaXhaaCU4KARwMa-q8KaarkrR9z1VDGiK4oJxUjap407VlZxrDjOk70ULXQk1VD7yq6Rl6f-g7Bn8_mZjk1uZZnFOD8VOU-Ts4bxjl_ycpAxC1gEy--4fc-CkMeYwMUYCmhCpD9QHSwccYTC_HYLcq7CUBOUclN3JORM6JyDkq-TcqucvWtw_9p3ZruqPxMZsMfDwAv60z-yc3lhfXq1llf3Hw25jM7uhX4ZcUFa24vL1ay_UPEOT69lxe0D8qi7Fe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733009207</pqid></control><display><type>article</type><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</creator><creatorcontrib>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</creatorcontrib><description>Aim:  Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population. Methods:  We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults. Results:  Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients. Conclusions:  These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</description><identifier>ISSN: 1034-4810</identifier><identifier>EISSN: 1440-1754</identifier><identifier>DOI: 10.1111/j.1440-1754.2010.01751.x</identifier><identifier>PMID: 20546101</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - pharmacology ; Antibiotic resistance ; Antibiotics ; Australia ; bacteremia ; bacterial ; Child ; Child, Preschool ; Children ; Clindamycin - pharmacology ; Clindamycin - therapeutic use ; Drug resistance ; Drug Resistance, Microbial - drug effects ; Hospitals, Pediatric ; Humans ; Infection ; Methicillin-Resistant Staphylococcus aureus ; Pediatrics ; Staphylococcal Infections - drug therapy ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus infections</subject><ispartof>Journal of paediatrics and child health, 2010-07, Vol.46 (7-8), p.404-411</ispartof><rights>2010 The Authors. Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians)</rights><rights>Journal compilation © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians)</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</citedby><cites>FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1440-1754.2010.01751.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1440-1754.2010.01751.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20546101$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolf, Joshua</creatorcontrib><creatorcontrib>Daley, Andrew J</creatorcontrib><creatorcontrib>Tilse, Martyn H</creatorcontrib><creatorcontrib>Nimmo, Graeme R</creatorcontrib><creatorcontrib>Bell, Sydney</creatorcontrib><creatorcontrib>Howell, Alison J</creatorcontrib><creatorcontrib>Keil, Anthony D</creatorcontrib><creatorcontrib>Lawrence, Andrew</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><title>Journal of paediatrics and child health</title><addtitle>J Paediatr Child Health</addtitle><description>Aim:  Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population. Methods:  We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults. Results:  Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients. Conclusions:  These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</description><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Australia</subject><subject>bacteremia</subject><subject>bacterial</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Clindamycin - pharmacology</subject><subject>Clindamycin - therapeutic use</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial - drug effects</subject><subject>Hospitals, Pediatric</subject><subject>Humans</subject><subject>Infection</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Pediatrics</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus infections</subject><issn>1034-4810</issn><issn>1440-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhS0EoqXwCshiwyrDdfyTZMFiNIIpVVUqFVQJCVmO46gePHFqO2Lm7XGYdhZsqBe-x_Z3rnR9EMIEFiSvD5sFYQwKUnG2KCHfQpZksXuGTo8Pz7MGygpWEzhBr2LcAEDJef0SnZTAmSBATtHP5ZBsa32yGscpajPOR2fTHo8qJROGiH2Pb5Ia7_bOa6_1FLGagsnFRu9UMhH3wW_xcoopKGfVgPWddV0ww2v0olcumjcP9Qx9__zp2-q8uPy6_rJaXhaaCU4KARwMa-q8KaarkrR9z1VDGiK4oJxUjap407VlZxrDjOk70ULXQk1VD7yq6Rl6f-g7Bn8_mZjk1uZZnFOD8VOU-Ts4bxjl_ycpAxC1gEy--4fc-CkMeYwMUYCmhCpD9QHSwccYTC_HYLcq7CUBOUclN3JORM6JyDkq-TcqucvWtw_9p3ZruqPxMZsMfDwAv60z-yc3lhfXq1llf3Hw25jM7uhX4ZcUFa24vL1ay_UPEOT69lxe0D8qi7Fe</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Wolf, Joshua</creator><creator>Daley, Andrew J</creator><creator>Tilse, Martyn H</creator><creator>Nimmo, Graeme R</creator><creator>Bell, Sydney</creator><creator>Howell, Alison J</creator><creator>Keil, Anthony D</creator><creator>Lawrence, Andrew</creator><creator>Curtis, Nigel</creator><general>Blackwell Publishing Asia</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope><scope>M7N</scope></search><sort><creationdate>201007</creationdate><title>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</title><author>Wolf, Joshua ; Daley, Andrew J ; Tilse, Martyn H ; Nimmo, Graeme R ; Bell, Sydney ; Howell, Alison J ; Keil, Anthony D ; Lawrence, Andrew ; Curtis, Nigel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4651-6050e4980e4a4c721bff5a919165635179a759db2de9e4eefd6b0db083af05783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Australia</topic><topic>bacteremia</topic><topic>bacterial</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Clindamycin - pharmacology</topic><topic>Clindamycin - therapeutic use</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial - drug effects</topic><topic>Hospitals, Pediatric</topic><topic>Humans</topic><topic>Infection</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Pediatrics</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolf, Joshua</creatorcontrib><creatorcontrib>Daley, Andrew J</creatorcontrib><creatorcontrib>Tilse, Martyn H</creatorcontrib><creatorcontrib>Nimmo, Graeme R</creatorcontrib><creatorcontrib>Bell, Sydney</creatorcontrib><creatorcontrib>Howell, Alison J</creatorcontrib><creatorcontrib>Keil, Anthony D</creatorcontrib><creatorcontrib>Lawrence, Andrew</creatorcontrib><creatorcontrib>Curtis, Nigel</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Journal of paediatrics and child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolf, Joshua</au><au>Daley, Andrew J</au><au>Tilse, Martyn H</au><au>Nimmo, Graeme R</au><au>Bell, Sydney</au><au>Howell, Alison J</au><au>Keil, Anthony D</au><au>Lawrence, Andrew</au><au>Curtis, Nigel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children</atitle><jtitle>Journal of paediatrics and child health</jtitle><addtitle>J Paediatr Child Health</addtitle><date>2010-07</date><risdate>2010</risdate><volume>46</volume><issue>7-8</issue><spage>404</spage><epage>411</epage><pages>404-411</pages><issn>1034-4810</issn><eissn>1440-1754</eissn><abstract>Aim:  Staphylococcus aureus is an important cause of serious illness in children. Antibiotic resistance is an international problem and affects initial antibiotic choice. We aimed to describe susceptibility patterns of S. aureus isolates from Australian children to inform optimal empiric treatment of staphylococcal infections in this population. Methods:  We analysed susceptibility data for all S. aureus isolates from children at Australian tertiary paediatric hospitals in 2006. Susceptibility rates were compared between hospitals and states, and with published studies of S. aureus isolates from Australian adults. Results:  Overall, the proportion of methicillin‐resistant S. aureus (MRSA) in Australian children was low (9.8%), and in each state it was less than for the comparable adult population. There were significant differences in susceptibility patterns between different states. Most MRSA isolates were susceptible to clindamycin (73%) and all isolates were reported as susceptible to vancomycin. Susceptibility patterns for isolates from bacteraemic patients were similar to those for isolates from all patients. Conclusions:  These data support current Australian recommendations for the use of flucloxacillin or a first‐generation cephalosporin as initial treatment of non‐life‐threatening staphylococcal infections. However, broad spectrum antibiotic therapy including agents that are effective against MRSA should be considered for more serious infections. Appropriate specimens should be collected for susceptibility testing to enable directed treatment for MRSA and other resistant organisms. This study highlights the importance of using local, age‐specific data in planning antibiotic treatment guidelines, as results vary substantially from city to city and between adults and children.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>20546101</pmid><doi>10.1111/j.1440-1754.2010.01751.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1034-4810
ispartof Journal of paediatrics and child health, 2010-07, Vol.46 (7-8), p.404-411
issn 1034-4810
1440-1754
language eng
recordid cdi_proquest_miscellaneous_754559435
source MEDLINE; Access via Wiley Online Library
subjects Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - pharmacology
Antibiotic resistance
Antibiotics
Australia
bacteremia
bacterial
Child
Child, Preschool
Children
Clindamycin - pharmacology
Clindamycin - therapeutic use
Drug resistance
Drug Resistance, Microbial - drug effects
Hospitals, Pediatric
Humans
Infection
Methicillin-Resistant Staphylococcus aureus
Pediatrics
Staphylococcal Infections - drug therapy
Staphylococcus aureus
Staphylococcus aureus - drug effects
Staphylococcus infections
title Antibiotic susceptibility patterns of Staphylococcus aureus isolates from Australian children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T01%3A29%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20susceptibility%20patterns%20of%20Staphylococcus%20aureus%20isolates%20from%20Australian%20children&rft.jtitle=Journal%20of%20paediatrics%20and%20child%20health&rft.au=Wolf,%20Joshua&rft.date=2010-07&rft.volume=46&rft.issue=7-8&rft.spage=404&rft.epage=411&rft.pages=404-411&rft.issn=1034-4810&rft.eissn=1440-1754&rft_id=info:doi/10.1111/j.1440-1754.2010.01751.x&rft_dat=%3Cproquest_cross%3E754559435%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733009207&rft_id=info:pmid/20546101&rfr_iscdi=true